1. The AIDS dementia complex: Clinical and basic Neuroscience with implications for novel molecular therapies

   • Bradford A. Navia
   • Kevin Rostasy

   Part I HIV-1 Asociated Dementia (HAD) Pages: 3 - 24

2. Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases

   • Irena Kadiu
   • Jason G. Glanzer
   • Mark P. Thomas

   Part I HIV-1 Asociated Dementia (HAD) Pages: 25 - 50

3. The shifting patterns of HIV encephalitis neuropathology

   • Ian P. Everall
   • Lawrence A. Hansen
   • Eliezer Masliah

   Part I HIV-1 Asociated Dementia (HAD) Pages: 51 - 61

4. Molecular targets of opiate drug abuse in neuro AIDS

   • Kurt F. Hauser
   • Nazira El-Hage
   • Pamela E. Knapp

   Part I HIV-1 Asociated Dementia (HAD) Pages: 63 - 80

5. Human brain derived cell culture models of HIV-1 infection

   • Pankaj Seth
   • Eugene O. Major

   Part II Experimental Models of Had Pages: 83 - 89

6. Rodent model systems for studies of HIV-1 associated dementia

   • Yuri Persidsky
   • Raghava Potula
   • James Haorah

   Part II Experimental Models of Had Pages: 91 - 106

7. The role of monocytes and perivascular macrophages in HIV and SIV neuropathogenesis: Information from non-human primate models

   • Woong-Ki Kim
   • Xavier Alvarez
   • Kenneth Williams

   Part II Experimental Models of Had Pages: 107 - 115

8. Molecular and cellular mechanisms of neuronal cell death in HIV dementia

   • W. Li
   • D. Galey
   • Avindra Nath

   Part III Molecular and Cellular Mechanisms of Neuronal Cell Death Pages: 119 - 134

9. The signaling and apoptotic effects of TNF-related apoptosis-inducing ligand in HIV-1 associated dementia

   • Y. Huang
   • N. Erdmann
   • J. Zheng

   Part III Molecular and Cellular Mechanisms of Neuronal Cell Death Pages: 135 - 148

10. HIV-1, chemokines and neurogenesis

    • Phuong B. Tran
    • Richard J. Miller

    Part III Molecular and Cellular Mechanisms of Neuronal Cell Death Pages: 149 - 158

11. Adjunctive therapies for HIV-1 associated neurologic disease

    • Seth W. Perry
    • John P. Norman
    • Harris A. Gelbard

    Part IV Neuroprotective Agents Pages: 161 - 166

12. Experimental and potential future therapeutic approaches for HIV-1 associated dementia targeting receptors for chemokines, glutamate and erythropoietin

    • Marcus Kaul
    • Stuart A. Lipton

    Part IV Neuroprotective Agents Pages: 167 - 186

13. Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration

    • Rachel L. Nosheny
    • Italo Mocchetti
    • Alessia Bachis

    Part IV Neuroprotective Agents Pages: 187 - 198